Version 1
: Received: 14 August 2023 / Approved: 14 August 2023 / Online: 14 August 2023 (16:01:25 CEST)
Version 2
: Received: 14 September 2023 / Approved: 15 September 2023 / Online: 18 September 2023 (13:31:36 CEST)
How to cite:
Regolo, M.; Cardaci, N.; Salmeri, C.; Laudani, A.; Colaci, M.; Ippolito, M.; Motta, F.; Magrì, S.; Parisi, S.; Torcitto, A. G.; Malatino, L. Pancreatic Neuroendocrine Tumor (P-NET) Presented by Abdominal Pain: Case Report and Literature Review. Preprints2023, 2023081058. https://doi.org/10.20944/preprints202308.1058.v2
Regolo, M.; Cardaci, N.; Salmeri, C.; Laudani, A.; Colaci, M.; Ippolito, M.; Motta, F.; Magrì, S.; Parisi, S.; Torcitto, A. G.; Malatino, L. Pancreatic Neuroendocrine Tumor (P-NET) Presented by Abdominal Pain: Case Report and Literature Review. Preprints 2023, 2023081058. https://doi.org/10.20944/preprints202308.1058.v2
Regolo, M.; Cardaci, N.; Salmeri, C.; Laudani, A.; Colaci, M.; Ippolito, M.; Motta, F.; Magrì, S.; Parisi, S.; Torcitto, A. G.; Malatino, L. Pancreatic Neuroendocrine Tumor (P-NET) Presented by Abdominal Pain: Case Report and Literature Review. Preprints2023, 2023081058. https://doi.org/10.20944/preprints202308.1058.v2
APA Style
Regolo, M., Cardaci, N., Salmeri, C., Laudani, A., Colaci, M., Ippolito, M., Motta, F., Magrì, S., Parisi, S., Torcitto, A. G., & Malatino, L. (2023). Pancreatic Neuroendocrine Tumor (P-NET) Presented by Abdominal Pain: Case Report and Literature Review. Preprints. https://doi.org/10.20944/preprints202308.1058.v2
Chicago/Turabian Style
Regolo, M., Alfredo Gaetano Torcitto and Lorenzo Malatino. 2023 "Pancreatic Neuroendocrine Tumor (P-NET) Presented by Abdominal Pain: Case Report and Literature Review" Preprints. https://doi.org/10.20944/preprints202308.1058.v2
Abstract
Pancreatic neuroendocrine tumor (P-NET) is a rare neoplasm originating in the neuroendocrine system. Carcinoid syndrome occurs in approximately 19% of patients with functional P-NETs, typically when liver metastases occur. NETs diagnosis is frequently late, along with symptoms related to hormone hypersecretion. We described the case of a patient with a low-grade non-functional P-NET, but with a typical clinical presentation of a carcinoid syndrome; moreover, we reviewed the literature regarding this topic. An 81-year-old male was admitted to our Department of Internal Medicine at Cannizzaro Hospital (Catania, Italy) because of the onset of abdominal pain with nausea, loose stools and episodic flushing. Firstly, an abdominal contrast-enhanced CT scan showed a small pancreatic hypervascular mass; then a gallium-68 DOTATOC integrated PET/CT revealed an elevated expression of SSTR receptors. Serum Chromogranin A and urinary 5-HIAA measurements resulted negative. Given the small size of the lesion (8 mm), we preferred to perform an endoscopic ultrasonography (EUS) with fine-needle biopsy (EUS-FNB), allowing the diagnosis of low-grade (G1) non-functional P-NET (NF-P-NET). Surgery was waived, while a follow-up strategy was chosen. Early recognition of P-NETs, although rare, is necessary to improve patient’s survival. EUS-FNB should be the protocol of choice for an early characterization of these tumors.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commenter: Lorenzo Malatino
Commenter's Conflict of Interests: Author